Warning: This tender is by micro-cap listed on pink-sheets – as such there is way more risk that the tender offer will be carried through as described. Do your own research before investing.
Current Price – $3.02;
Offer Price – $3.25;
Upside – 7% or $22 (for odd lot holders)
Expiration date – 28 July 2015
Cryo-Cell International, Inc., a Delaware corporation, is offering to purchase up to 750,000 shares of its common stock, par value $0.01 per share, at a price of $3.25 per share, net to the seller in cash. The 750,000 shares that Cryo-Cell is offering to purchase represent approximately 7.76% of the shares outstanding on June 22, 2015
No proration for Odd Lot holders:
Odd Lots. For purposes of the tender offer, the term “odd lots” shall mean all shares properly tendered prior to the expiration date and not properly withdrawn by any person referred to as an “odd lot holder” who owns beneficially or of record an aggregate of fewer than 100 shares and so certifies in the appropriate place on the Letter of Transmittal and, if applicable, on the Notice of Guaranteed Delivery. To qualify for this preference, an odd lot holder must tender all shares owned beneficially or of record by the odd lot holder in accordance with the procedures described in Section 3. As set forth above, odd lots will be accepted for payment before proration, if any, of the purchase of other tendered shares.
Source of Funds:
Assuming Cryo-Cell purchases 750,000 shares in the tender offer, approximately $2,437,500 will be required to purchase such shares. Cryo-Cell currently possesses the cash funds necessary to purchase shares tendered in the tender offer, as well as to pay related fees and expenses. The tender offer is not conditioned upon the receipt of financing. See Section 7. Cryo-Cell does not have any alternative financing plans for this tender, including any borrowings.